On January 15, 2015, the USPTO’s Patent Trial and Appeal Board (“Board”) issued final written decisions relating to three Petitions seeking inter partes review filed by Cardiocom, LLC (“Petitioner”), with Medronic, Inc. also indicated as a real party-in-interest to the proceedings. The three Petitions involved inter partes review of (i) claims 1-22 of U.S. Patent No. 7,587,469 (“the ‘469 Patent”), (ii) claims 1-5 of U.S. Patent No. 7,840,420 (“the ‘420 Patent”), and (iii) claims 1-16 of U.S. Patent No. 7,921,186 (“the ‘186 Patent). The ‘469 Patent, the ‘420 Patent, and the‘186 Patent are all owned by Robert Bosch Healthcare Systems, Inc., and are drawn to systems for remote monitoring of individuals and/or methods for collecting data relating to the health status of a patient and communicating information to patients. In each of the final written decisions, the Board determined that Petitioner had shown by a preponderance of the evidence that the claims of each of the asserted patents are unpatentable. The cases remain pending and are captioned IPR2013-00451, IPR2013-00449, and IPR2013-00431, respectively.
By: Jacqueline A. DiRamio